Skip Navigation
KO EN JP CN
Main Careers
Menu
MainCareers
Locations Contacts
Close
Search

Kevin Kyumin LEE Foreign Attorney (Admitted in New York and Connecticut)

T.+82-2-2122-3534 F.+82-2-2122-3800
Kevin Kyumin LEE Foreign Attorney
pdf vcard print
Kevin Kyumin LEE Foreign Attorney

Kevin Kyumin LEEForeign Attorney (Admitted in New York and Connecticut)

T.+82-2-2122-3534F.+82-2-2122-3800E.kklee@kimchang.com

PDF vcard

Areas of Expertise

Overview

Kevin Lee is a senior foreign attorney at the firm focusing on cross border pharmaceutical patent litigation.  His work scope includes patent infringement, invalidation, scope confirmation actions and appeals within the Korean courts and patent office.  He particularly specializes in biotechnology matters such as matters related to biosimilars, cell and gene therapy, stem cells, RNA based pharmaceuticals and other cutting edge issues in the field.  He also advises clients on regulatory, import/export, and fair trade issues in the pharmaceutical space.  He is admitted in New York and Connecticut, and registered to practice before the USPTO.  Prior to becoming an attorney, he did his doctorate and postdoctorate work in the area of chromatin structure and gene expression.

View More

Profile

Experience

Kim & Chang (2006-Present)

Bristol-Myers Squibb Company, Princeton, NJ (2006)

Frommer Lawrence & Haug LLP, New York, NY (2005-2006)

Fish & Neave, New York, NY (2001-2004)

Postdoctoral Fellow, Harvard Medical School, Boston, MA (1999-2001)

Postdoctoral Fellow, National Institutes of Health, Bethesda, MD (1998-1999)

Representative ActivitiesView All

Awards

  • NRSA Postdoctoral Fellowship, National Institutes of Health
  • MGH Fund for Medical Discovery Fellowship, Massachusetts General Hospital

Publications/Activities
    • Speaker, Biosimilars North America, Smi Conference, Iselin, NJ (2016)
    • Speaker, BIO IPCC Fall Conference and Meeting, Raleigh NC (2015)
    • Biosimilars in "Draft legislation on Patent-Regulatory Approval Linkage System" ILO Newsletter (2014)
    • Speaker, "Biosimilars," ACI Conference on Biosimilars, New York (2012)
    • "Handbook on US Biosimilar Act," KFDA Official Publication (2011)
    • Speaker, "US Biosimilars Act," Korea Biotechnology Industry Association, Seoul (2011)
    • Speaker, "Biobetters and Biosimilars," KHIDI, Seoul (2010)
    • Speaker, "Patents and Cell Therapy," KFDA Workshop, Seoul (2010)
    • Speaker, "Korean Patent Practice," ACI Conference on Foreign Patent Law and Regulation, New York (2009)
    • "Lower Court in Key Injunction Ruling," International Briefings, Managing IP, (2008)
    • "A Question of Ownership," Asia-Pacific Focus, Managing IP, (2007)
    • "Assembly of Nucleosome Templates by Salt Dialysis' Current Protocols in Molecular Biology," Ausubel et al. Ed. Wiley Press. 21.6.1-26. (2001)
    • "Dual Functions of Largest NURF Subunit NURF301 in Nucleosome Sliding and Transcription Factor Interactions," Mol. Cell. 8, 531-43 (2001)
    • "hSWI/SNF Disrupts Interactions Between the H2A N-terminal Tail and Nucleosomal DNA," Biochemistry. 38, 8423-9 (1999)
    • "Targeted Crosslinking and DNA Cleavage Within Model Chromatin Complexes," Meth. Enzymol. 304, 231-251 (1999)
    • "Site-Directed Chemical Probing of Histone-DNA Interactions," Meth. Mol. Biol. Series 'Chromatin Protocols', P.B. Becker Ed., Humana Press, 27-43 (1999)
    • "Linker Histone-Dependent Reorganization of Histone-DNA Interactions Within the Nucleosome," Biochemistry. 37, 8622-8628 (1998)
    • "The N-terminal Tail of Histone H2A Binds to Two Distinct Sites Within the Nucleosome," Proc. Natl. Acad. Sci. USA 94, 8959-8964 (1997)

Education

Fordham University, School of Law (J.D., 2005)

University of Rochester (Ph.D., Biochemistry, 1998)

Korea University (B.S., Biology, 1991)

Qualifications

Admitted to bar, New York, 2006; Connecticut, 2006 

Registered to practice before the U.S. Patent and Trademark Office, 2002

Languages

English and Korean

Insights

View More

Professionals

EXPERTISE RESET SEARCH

EXPERTISE

Close

EXPERTISE

Close

Share

Share
  

Kevin Kyumin LEE
Foreign Attorney (Admitted in New York and Connecticut)


T. +82-2-2122-3534      
F. +82-2-2122-3800      
  




Kevin Lee is a senior foreign attorney at the firm focusing on cross border pharmaceutical patent litigation.  His work scope includes patent infringement, invalidation, scope confirmation actions and appeals within the Korean courts and patent office.  He particularly specializes in biotechnology matters such as matters related to biosimilars, cell and gene therapy, stem cells, RNA based pharmaceuticals and other cutting edge issues in the field.  He also advises clients on regulatory, import/export, and fair trade issues in the pharmaceutical space.  He is admitted in New York and Connecticut, and registered to practice before the USPTO.  Prior to becoming an attorney, he did his doctorate and postdoctorate work in the area of chromatin structure and gene expression.






    Kim & Chang (2006-Present)

    Bristol-Myers Squibb Company, Princeton, NJ (2006)

    Frommer Lawrence & Haug LLP, New York, NY (2005-2006)

    Fish & Neave, New York, NY (2001-2004)

    Postdoctoral Fellow, Harvard Medical School, Boston, MA (1999-2001)

    Postdoctoral Fellow, National Institutes of Health, Bethesda, MD (1998-1999)






Awards

  •   NRSA Postdoctoral Fellowship, National Institutes of Health
  •   MGH Fund for Medical Discovery Fellowship, Massachusetts General Hospital

Publications/Activities

  •   Speaker, Biosimilars North America, Smi Conference, Iselin, NJ (2016)
  •   Speaker, BIO IPCC Fall Conference and Meeting, Raleigh NC (2015)
  •   Biosimilars in "Draft legislation on Patent-Regulatory Approval Linkage System" ILO Newsletter (2014)
  •   Speaker, "Biosimilars," ACI Conference on Biosimilars, New York (2012)
  •   "Handbook on US Biosimilar Act," KFDA Official Publication (2011)
  •   Speaker, "US Biosimilars Act," Korea Biotechnology Industry Association, Seoul (2011)
  •   Speaker, "Biobetters and Biosimilars," KHIDI, Seoul (2010)
  •   Speaker, "Patents and Cell Therapy," KFDA Workshop, Seoul (2010)
  •   Speaker, "Korean Patent Practice," ACI Conference on Foreign Patent Law and Regulation, New York (2009)
  •   "Lower Court in Key Injunction Ruling," International Briefings, Managing IP, (2008)
  •   "A Question of Ownership," Asia-Pacific Focus, Managing IP, (2007)
  •   "Assembly of Nucleosome Templates by Salt Dialysis' Current Protocols in Molecular Biology," Ausubel et al. Ed. Wiley Press. 21.6.1-26. (2001)
  •   "Dual Functions of Largest NURF Subunit NURF301 in Nucleosome Sliding and Transcription Factor Interactions," Mol. Cell. 8, 531-43 (2001)
  •   "hSWI/SNF Disrupts Interactions Between the H2A N-terminal Tail and Nucleosomal DNA," Biochemistry. 38, 8423-9 (1999)
  •   "Targeted Crosslinking and DNA Cleavage Within Model Chromatin Complexes," Meth. Enzymol. 304, 231-251 (1999)
  •   "Site-Directed Chemical Probing of Histone-DNA Interactions," Meth. Mol. Biol. Series 'Chromatin Protocols', P.B. Becker Ed., Humana Press, 27-43 (1999)
  •   "Linker Histone-Dependent Reorganization of Histone-DNA Interactions Within the Nucleosome," Biochemistry. 37, 8622-8628 (1998)
  •   "The N-terminal Tail of Histone H2A Binds to Two Distinct Sites Within the Nucleosome," Proc. Natl. Acad. Sci. USA 94, 8959-8964 (1997)





Education

    Fordham University, School of Law (J.D., 2005)

    University of Rochester (Ph.D., Biochemistry, 1998)

    Korea University (B.S., Biology, 1991)


Qualifications

    Admitted to bar, New York, 2006; Connecticut, 2006 

    Registered to practice before the U.S. Patent and Trademark Office, 2002


Languages
  •    English and Korean





Patent & Utility Model ,  Chemicals ,  Intellectual Property Dispute ,  Intellectual Property ,  Environment ,  US